Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole E Fletcher

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Immunity & Inflammation|February 11, 2026
Leveraging T cells for cancer immunotherapyAdam Bates, Nicole E Fletcher, Fei Gao, et al.
Cancer Research Communications|July 12, 2024
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist TherapyCharlotte J Imianowski, Paula Kuo, Sarah K Whiteside, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Immunity & Inflammation|February 11, 2026
Leveraging T cells for cancer immunotherapyAdam Bates, Nicole E Fletcher, Fei Gao, et al.
Cancer Research Communications|July 12, 2024
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist TherapyCharlotte J Imianowski, Paula Kuo, Sarah K Whiteside, et al.
Pageof 1